JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB219648

Anti-CD276 antibody [EPR20115]

  • RabMAb
  • Recombinant
  • KO Validated
  • 20ul selling size
  • What is this?

4

(1 Review)

|

(12 Publications)

Anti-CD276 antibody [EPR20115] (ab219648) is a rabbit monoclonal antibody detecting CD276 in Western Blot, IHC-P. Suitable for Human.

- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency

View Alternative Names

CD276, B7H3, PSEC0249, UNQ309/PRO352, CD276 antigen, 4Ig-B7-H3, B7 homolog 3, Costimulatory molecule, B7-H3

10 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD276 antibody [EPR20115] (AB219648)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD276 antibody [EPR20115] (AB219648)

Immunohistochemical analysis of paraffin-embedded human placenta tissue labeling CD276 with ab219648 at 1/4000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Cytoplasmic and membranous staining on vascular endothelial cells and trophoblast cells of human placenta is observed.

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD276 antibody [EPR20115] (AB219648)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD276 antibody [EPR20115] (AB219648)

Immunohistochemical analysis of paraffin-embedded human lung carcinoma tissue labeling CD276 with ab219648 at 1/4000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Membranous staining on human lung carcinoma is observed [PMID : 25609202].

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD276 antibody [EPR20115] (AB219648)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD276 antibody [EPR20115] (AB219648)

Immunohistochemical analysis of paraffin-embedded human skeletal muscle tissue labeling CD276 with ab219648 at 1/4000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Negative tissue : no staining on human skeletal muscle. [PMID : 18975328].

Counter stained with Hematoxylin.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD276 antibody [EPR20115] (AB219648)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD276 antibody [EPR20115] (AB219648)

Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling CD276 with ab219648 at 1/4000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Membranous staining on dendritic cells of human tonsil is observed.

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD276 antibody [EPR20115] (AB219648)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD276 antibody [EPR20115] (AB219648)

Immunohistochemical analysis of paraffin-embedded human breast cancer tissue labeling CD276 with ab219648 at 1/4000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Membranous and cytoplasmic staining on human breast cancer tumor cells and stromal cells is observed.

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD276 antibody [EPR20115] (AB219648)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD276 antibody [EPR20115] (AB219648)

Immunohistochemical analysis of paraffin-embedded human hepatocellular carcinoma tissue labeling CD276 with ab219648 at 1/4000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Membranous staining on human hepatocellular carcinoma is observed.

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Western blot - Anti-CD276 antibody [EPR20115] (AB219648)
  • WB

Supplier Data

Western blot - Anti-CD276 antibody [EPR20115] (AB219648)

Blocking/Dilution buffer : 5% NFDM/TBST.

Exposure time : Lane 1/2 : 30 seconds; Lane 3 : 10 seconds.

All lanes:

Western blot - Anti-CD276 antibody [EPR20115] (ab219648) at 1/1000 dilution

Lane 1:

Human lung lysate at 10 µg

Lane 2:

Human skin lysate at 10 µg

Lane 3:

Human placenta lysate at 10 µg

Secondary

All lanes:

Western blot - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/4000 dilution

Predicted band size: 57 kDa

Observed band size: 90-110 kDa

false

Western blot - Anti-CD276 antibody [EPR20115] (AB219648)
  • WB

Supplier Data

Western blot - Anti-CD276 antibody [EPR20115] (AB219648)

Blocking/Dilution buffer : 5% NFDM/TBST.

Raji cells were used as a negative control for CD276 (B7-H3) (PMID : 21344157).

Negative control : lane 2 Raji cell lysate

All lanes:

Western blot - Anti-CD276 antibody [EPR20115] (ab219648) at 1/1000 dilution

Lane 1:

LNCaP (Human prostate cancer cell line) whole cell lysate at 10 µg

Lane 2:

Raji (Human Burkitt's lymphoma cell line) whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 57 kDa

Observed band size: 90-110 kDa

false

Exposure time: 3s

Western blot - Anti-CD276 antibody [EPR20115] (AB219648)
  • WB

Lab

Western blot - Anti-CD276 antibody [EPR20115] (AB219648)

Lanes 1-4 : Merged signal (red and green). Green - ab219648 observed at 90-110 kDa. Red - loading control ab8245 observed at 36 kDa.

ab219648 Anti-CD276 antibody [EPR20115] was shown to specifically react with CD276 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line ab266658 (knockout cell lysate ab257097) was used. Wild-type and CD276 knockout samples were subjected to SDS-PAGE. ab219648 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-CD276 antibody [EPR20115] (ab219648) at 1/1000 dilution

Lane 1:

Wild-type HEK293T cell lysate at 20 µg

Lane 2:

CD276 knockout HEK293T cell lysate at 20 µg

Lane 2:

Western blot - Human CD276 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-cd276-knockout-hek-293t-cell-line-ab266658'>ab266658</a>)

Lane 3:

LNCaP cell lysate at 20 µg

Lane 4:

Raji cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution

Predicted band size: 57 kDa

Observed band size: 90-110 kDa

false

Western blot - Anti-CD276 antibody [EPR20115] (AB219648)
  • WB

Supplier Data

Western blot - Anti-CD276 antibody [EPR20115] (AB219648)

Blocking/Dilution buffer : 5% NFDM/TBST.

CD276 (B7-H3) has a molecular weight of about 90–100 kDa, depending on the glycosylation levels. [PMID : 22473715].

All lanes:

Western blot - Anti-CD276 antibody [EPR20115] (ab219648) at 1/2000 dilution

Lane 1:

U-2OS (Human bone osteosarcoma epithelial cell line) whole cell lysate at 10 µg

Lane 2:

PC-3 (Human prostate adenocarcinoma cell line) whole cell lysate at 10 µg

Lane 3:

293T (Human epithelial cell line from embryonic kidney) whole cell lysate at 10 µg

Lane 4:

MDA-MB-435S (Human ductal carcinoma cell line) whole cell lysate at 10 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 57 kDa

Observed band size: 90-110 kDa

false

Exposure time: 3s

  • Carrier free

    Anti-CD276 antibody [EPR20115] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR20115

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/4000", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." } } }

Product details

What is this antibody validated in?
Anti-CD276 antibody [EPR20115] (ab219648) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human samples.

What is the molecular weight of CD276?
Anti-CD276 [EPR20115] (ab219648) specifically detects a band for CD276 (UniProt: Q5ZPR3) at a molecular weight of 57kDa.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Specificity confirmed
The specificity of Anti-CD276 antibody [EPR20115] (ab219648) has been confirmed by Western blot testing in CD276 Knockout HEK293T cell line, ab266658.

Other related products
We have a range of other formats of antibody clone [EPR20115] also available for your convenience: ab219648, Carrier free - ab227577, Carrier free - ab302848

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

CD276 also known as B7-H3 is an immunoregulatory protein with a mass of approximately 57 kDa although post-translational modifications can increase its observed size. It is a member of the B7 family which is part of the immunoglobulin superfamily. CD276 is widely expressed in various tissues including placenta liver heart and also in many tumor cells. It is observed in lesser amounts in normal tissues making it an interesting target for cancer research. Various assays like HEK293 and HEK293T cell confluency studies often use CD276 to explore its expression under different conditions and seeding densities which are represented in confluency charts.
Biological function summary

CD276 modulates immune responses by acting as a co-inhibitory ligand impacting T-cell proliferation and cytokine synthesis. Not part of a known complex it plays a role in the adaptive immune system by providing negative feedback regulation that can inhibit the immune response. This capability has implications in preventing autoimmunity but may also contribute to tumor immune evasion by reducing effective anti-tumor responses. The B7-H3/CD276 interaction with receptors such as IL receptor family members suggests its diverse immunomodulatory functions.

Pathways

CD276 participates in the T-cell receptor (TCR) signaling pathways influencing immune checkpoint pathways. It interacts with other immune checkpoint proteins like PD-L1 and CTLA-4 but its exact receptor partner remains unidentified. The presence of CD276 in these pathways highlights its role in controlling T-cell activation and tolerance. By modulating TCR signals and impacting downstream effects CD276 serves as a regulatory point that can balance immune activation and inhibition critical in immune-mediated conditions.

CD276 has strong associations with cancer particularly in solid tumors such as prostate and breast cancer. It is often overexpressed in malignant tissues contributing to immune evasion by tumors. Researchers propose it as a potential target for cancer immunotherapy due to this attribute. CD276's link to disorders like asthma has also been suggested where its interaction with proteins involved in inflammatory pathways such as IL response elements can exacerbate the condition. This implicates it as a dual-role protein in both disease progression and potential therapeutic targeting.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

May participate in the regulation of T-cell-mediated immune response. May play a protective role in tumor cells by inhibiting natural-killer mediated cell lysis as well as a role of marker for detection of neuroblastoma cells. May be involved in the development of acute and chronic transplant rejection and in the regulation of lymphocytic activity at mucosal surfaces. Could also play a key role in providing the placenta and fetus with a suitable immunological environment throughout pregnancy. Both isoform 1 and isoform 2 appear to be redundant in their ability to modulate CD4 T-cell responses. Isoform 2 is shown to enhance the induction of cytotoxic T-cells and selectively stimulates interferon gamma production in the presence of T-cell receptor signaling.
See full target information CD276

Publications (12)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:7035 PubMed40745160

2025

Mogat1 drives metabolic adaptations to evade immune surveillance.

Applications

Unspecified application

Species

Unspecified reactive species

Huan Wei,Congyi Niu,Yue Shi,Yingfei Fang,Chengheng Yang,Jian Liu,Zhenjie Xu

Research (Washington, D.C.) 8:0590 PubMed39845707

2025

Altered Atlas of Exercise-Responsive MicroRNAs Revealing miR-29a-3p Attacks Armored and Cold Tumors and Boosts Anti-B7-H3 Therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Jie Mei,Zhiwen Luo,Yun Cai,Renwen Wan,Zhiwen Qian,Jiahui Chu,Yaying Sun,Yuxin Shi,Ying Jiang,Yan Zhang,Yongmei Yin,Shiyi Chen

Journal of translational medicine 22:809 PubMed39217342

2024

AC099850.3 promotes HBV-HCC cell proliferation and invasion through regulating CD276: a novel strategy for sorafenib and immune checkpoint combination therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Aoxiao He,Zhihao Huang,Qian Feng,Shan Zhang,Fan Li,Dan Li,Hongcheng Lu,Jiakun Wang

Cancer cell international 24:205 PubMed38858701

2024

Comprehensive characterization of B7 family members in breast cancer: B7-H5 switch reverses breast cancer from "immuno-cold" into "immuno-hot" status.

Applications

Unspecified application

Species

Unspecified reactive species

Jiayu Liu,Cenzhu Wang,Ying Jiang,Yunxu Zhou,Lingyan Chen,Zhiwen Qian,Lu Liu,Danping Wu,Yan Zhang

Diagnostic pathology 19:77 PubMed38858715

2024

B7-H3 and ICAM-1 are potentially therapeutic targets for thyroid carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Pengtao Song,Yongcan Xu,Guochao Ye

Cancer communications (London, England) 44:554-575 PubMed38507505

2024

Conserved immuno-collagenic subtypes predict response to immune checkpoint blockade.

Applications

Unspecified application

Species

Unspecified reactive species

Jie Mei,Yun Cai,Rui Xu,Qing Li,Jiahui Chu,Zhiwen Luo,Yaying Sun,Yuxin Shi,Junying Xu,Di Li,Shuai Liang,Ying Jiang,Jiayu Liu,Zhiwen Qian,Jiaofeng Zhou,Mengyun Wan,Yunlong Yang,Yichao Zhu,Yan Zhang,Yongmei Yin

Scientific reports 14:3901 PubMed38365809

2024

Cross-talk between disulfidptosis and immune check point genes defines the tumor microenvironment for the prediction of prognosis and immunotherapies in glioblastoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yanjun Zhou,Xue Qin,Qunchao Hu,Shaolei Qin,Ran Xu,Ke Gu,Hua Lu

NPJ breast cancer 10:11 PubMed38280882

2024

High B7-H3 expression with low PD-L1 expression identifies armored-cold tumors in triple-negative breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jie Mei,Yun Cai,Hongjun Zhu,Ying Jiang,Ziyi Fu,Junying Xu,Lingyan Chen,Kai Yang,Jinlu Zhao,Chenghu Song,Yan Zhang,Wenjun Mao,Yongmei Yin

BMC cancer 22:584 PubMed35624419

2022

Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jiayue Yang,Zhen Tian,Han Gao,Fan Xiong,Cuiping Cao,Jiaojiao Yu,Wei Shi,Qiang Zhan,Cheng Yang

Molecular cancer therapeutics 21:903-913 PubMed35312779

2022

Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma.

Applications

Unspecified application

Species

Unspecified reactive species

Yifei Wang,Xiangjun Tian,Wendong Zhang,Zhongting Zhang,Rossana Lazcano,Pooja Hingorani,Michael E Roth,Jonathan D Gill,Douglas J Harrison,Zhaohui Xu,Sylvester Jusu,Sankaranarayanan Kannan,Jing Wang,Alexander J Lazar,Eric J Earley,Stephen W Erickson,Tara Gelb,Philip Huxley,Johanna Lahdenranta,Gemma Mudd,Raushan T Kurmasheva,Peter J Houghton,Malcolm A Smith,Edward A Kolb,Richard Gorlick
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com